Role of melatonin in embryo fetal development

S E Voiculescu, N Zygouropoulos, C D Zahiu, A M Zagrean, S E Voiculescu, N Zygouropoulos, C D Zahiu, A M Zagrean

Abstract

Melatonin is an indoleamine produced by the pineal gland and secreted in a circadian manner. In the past few decades, research over this topic has been enhanced. Melatonin has many important roles in the human physiology: regulator of the circadian rhythms, sleep inducer, antioxidant, anticarcinogenic. This paper reviews the involvement of melatonin in embryo fetal development. The pineal gland develops completely postpartum, so both the embryo and the fetus are dependent on the maternal melatonin provided transplacentally. Melatonin appears to be involved in the normal outcome of pregnancy beginning with the oocyte quality and finishing with the parturition. Its pregnancy night-time concentrations increase after 24 weeks of gestation, with significantly high levels after 32 weeks. Melatonin receptors are widespread in the embryo and fetus since early stages. There is solid evidence that melatonin is neuroprotective and has a positive effect on the outcome of the compromised pregnancies. In addition, chronodisruption leads to a reproductive dysfunction. Thus, the influence of melatonin on the developing human fetus may not be limited to the entertaining of circadian rhythmicity, but further studies are needed.

Keywords: circadian rhythm; embryo-fetal development; melatonin.

References

    1. Reiter RJ, Tan DX, Galano A. Melatonin: Exceeding Expectations Physiology (Bethesda) 2014 Sep;29(5):325–333.
    1. Cajochen C, Krauchi K, Wirz-Justice A. Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep. Journal of Neuroendocrinology. 2003;15:432–437.
    1. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH. Daily rhythm in human urinary melatonin. Science. 1975;187:169–171.
    1. Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S, Sagara Y. Maternal–fetal transfer of melatonin in pregnant women near term. J Pineal Res. 1998 Oct;25(3):129–345.
    1. Kennaway DJ. Melatonin and development: physiology and pharmacology. Semin Perinatol. 2000;24:258–266.
    1. Kivela A, Kauppila A, Leppaluoto J, Vakkuri O. Serum and amniotic fluid melatonin during human labor. J Clin Endocrinol Metab. 1989;69:1065–1068.
    1. Nakamura Y, Tamura H, Kashida S, Takayama H, Yamagata Y, Karube A, Sugino N, Kato H. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001;30:29–33.
    1. Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci. 2010;14:555.
    1. Gitto E, Marseglia L, Manti S, D’Angelo G, Barberi I, Salpietro C, Reiter RJ. Protective Role of Melatonin in Neonatal Diseases. Oxidative Medicine and Cellular Longevity. 2013 Article ID 980374.
    1. Kivelä A. Serum melatonin during human pregnancy. Acta Endocrinol (Copenh) 1991 Mar;124(3):233–237.
    1. Naamura Y. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. Journal of Pineal Research. 2001 Jan;30(1):29–33.
    1. Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA. MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential. J. Med. Chem. 2014;57(8):3161–3185.
    1. Drew JE, Williams LM, Hannah LT, Barrett P, Abramovich DR. Melatonin receptors in the human fetal kidney: 2-[125I]iodomelatonin binding sites correlated with expression of Mel1a and Mel1b receptor genes. J Endocrinol. 1998;156(2):261–267.
    1. Thomas L, Purvis CC, Drew JE, Abramovich DR, Williams LM. Melatonin receptors in human fetal brain: 2-[(125)I]iodomelatonin binding and MT1 gene expression. J Pineal Res. 2002;33(4):218–224.
    1. Rivkees SA, Reppert SM. Appearance of melatonin receptors during embryonic life in Siberian hamsters (Phodopus sungorous) Brain Research. 1991;568(1-2):345–349.
    1. Torres-Farfan C, Valenzuela FJ, Mondaca M, Valenzuela GJ, Krause B, Herrera EA, Riquelme R, Llanos AJ, Seron-Ferre M. Evidence of a role for melatonin in fetal sheep physiology: direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland. The Journal of Physiology. 2008 Aug 15;586:4017–4027.
    1. Vaněček J. The Melatonin Receptors in Rat Ontogenesis. Neuroendocrinology. 1988;48:201–203.
    1. Ishizuka B, Kuribayashi Y, Murai K, Amemiya A, Itoh MT. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res. 2000;28:48–51.
    1. Tian XZ, Wen Q, Shi JM, Liang-Wang , Zeng SM, Tian JH, Zhou GB, Zhu SE, Liu GS. Effects of melatonin on in vitro development of mouse two-cell embryos cultured in HTF medium. Endocr Res. 2010 Jan;35(1):17–23.
    1. Sampaio RV, Conceição DSB, Moysés SM, Sampaio LFS, Ohashi OM. MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro. Reproductive Biology and Endocrinology. 2012;10:103.
    1. Mendez N, Abarzua-Catalan L, Vilches N, Galdames HA, Spichiger C, Richter HG, Valenzuela GJ, Seron-Ferre M, Torres-Farfan C. Timed Maternal Melatonin Treatment Reverses Circadian Disruption of the Fetal Adrenal Clock Imposed by Exposure to Constant Light. PLoS One. 2012;7(8):e42713.
    1. Torres-Farfan C, Richter HG, Germain AM, Valenzuela GJ, Campino C, Rojas-García P, Forcelledo ML, Torrealba F, Serón-Ferré M. Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland. J Physiol. 2004 Feb 1;554(Pt 3):841–856.
    1. Kennaway DJ, Stamp GE, Goble FC. Development of melatonin production in infants and the impact of prematurity. J Clin. Endocrinol Metab. 1992 Aug;75(2):367–369.
    1. Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and pregnancy in the human. Reprod. Toxicol. 2008;25:291–303.
    1. Labyak S, Lava S, Turek F, Zee P. Effects of shift work on sleep and menstrual function in nurses. Health Care for Women International. 2002;23(6-7):703–714.
    1. Knutsson A. Health disorders of shift workers. Occupational Medicine. 2003;53(2):103–108.
    1. Chung FF, Yao CCC, Wan GH. The associations between menstrual function and life style/working conditions among nurses in Taiwan. J Occupational Health. 2005;47(2):149–156.
    1. Knutsson A. Health disorders of shift workers. Occupational Medicine. 2003;53(2):103–108.
    1. Davis S, Mirick DK, Chen C, Stanczyk FZ. Night Shift Work and Hormone Levels in Women Cancer. Epidemiol Biomarkers Prev. 2012 Apr;21:609.
    1. Baumgartner A, Dietzel M, Saletu B, et al. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women. PsychiatryResearch. 1993;48(2):153–178.
    1. Unfer V, Raffone E, Rizzo P, et al. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol. 2011;27:857–861.
    1. Tamura H, Nakamura Y, Terron MP, et al. Melatonin and pregnancy in the human. Reprod Toxicol. 2008;25:291–303.
    1. Okatani Y, Okamoto K, Hayashi K, et al. Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res. 1998;25:129–134.
    1. Barchas J, Dacosta F, Spector S. Acute pharmacology of melatonin. Nature. 1967;214:919–920.
    1. Wurtman RJ, Axelrod J, Potter LT. The uptake of H3-melatonin in endocrine and nervous tissues and the effects of constant light exposure. J Pharmacol Exp Ther. 1964;143:314–318.
    1. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab. 1987;64:865–867.
    1. Olakowska E, Marcol W, Kotulska K, Lewin-Kowalik The role of melatonin in the neurodegenerative diseases. J Bratisl Lek Listy. 2005;106(4-5):171–174.
    1. Welin AK, Svedin P, Lapatto R, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res. 2007;61:153–158.
    1. Yawno T, Castillo-Melendez M, Jenkin G, et al. Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia. Dev Neurosci. 2012;34:543–551.
    1. Supramaniam VG, Jenkin G, Loose J, et al. Chronic fetal hypoxia increases activin A concentrations in the late-pregnant sheep. BJOG Int J Obstet Gynaecol. 2006;113:102–109.
    1. Thakor AS, Herrera EA, Serón Ferré M, et al. Melatonin and vitamin C increase umbilical blood flow via nitric oxide dependent mechanisms. J Pineal Res. 2010;49:399–406.
    1. Miller SL, Yan EB, Castillo-Melendez M, et al. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci. 2005;27:200–210.
    1. Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J. Pineal Res. 2001;31:343–349.
    1. Bouchlariotou S, Liakopoulos V, Giannopoulou M, Arampatzis S, Eleftheriadis T, Mertens PR, Zintzaras E, Messinis IE, Stefanidis I. Melatonin secretion is impaired in women with preeclampsia and abnormal circadian blood pressure rhythm. Renal Failure. 2014 Aug;36(7):1001–1007.
    1. Irmak MK, Topal T, Oter S. Melatonin seems to be a mediator that transfers the environmental stimuli to oocytes for inheritance of adaptive changes through epigenetic inheritance system. Medical Hypotheses. 2005:1138–1143.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit